SCHEMBL3272079

SCHEMBL3272079

N#CC1(c2ccc(OCC3CNC3)cc2)CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.41
SLC6A4 P31645 5/20 0.41
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SLC6A3 Q01959 3/20 0.38
GRM2 Q14416 1/20 0.36
HTR3A P46098 1/20 0.36
KCNH2 Q12809 1/20 0.36
FFAR4 Q5NUL3 2/20 0.35
SIGMAR1 Q99720 3/20 0.33
TDP1 Q9NUW8 1/20 0.33
TBK1 Q9UHD2 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM1A O60341 2/20 0.32
HRH3 Q9Y5N1 2/20 0.32
HRH2 P25021 1/20 0.32
HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3277449 0.80 POLB (0.44) POLBCYP3A4CYP2D6NPSR1GRM2
SCHEMBL3277203 0.79 HRH3 (0.41) POLBCYP3A4CYP2D6NPSR1GRM2
SCHEMBL31540195 0.77 ESR1 (0.38) SLC6A2SLC6A4SLC6A3GRM2TDP1
SCHEMBL3272966 0.76 OPRM1 (0.40) POLBCYP3A4CYP2D6NPSR1GRM2
SCHEMBL3272142 0.76 POLB (0.43) POLBCYP3A4CYP2D6NPSR1KCNH2
SCHEMBL3274822 0.75 SLC6A4 (0.41) SLC6A2SLC6A4CYP3A4CYP2D6NPSR1
SCHEMBL3272023 0.75 CYP3A4 (0.42) POLBCYP3A4CYP2D6NPSR1KCNH2
SCHEMBL3276033 0.74 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3GRM2KCNH2
SCHEMBL2240382 0.74 SLC6A2 (0.61) SLC6A2SLC6A4SLC6A3HTR3AKCNH2
SCHEMBL9966478 0.74 MAOB (0.51) SLC6A2SLC6A3FFAR4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747210-B1 3- OR 4-MONOSUBSTITUTED PHENOL AND THIOPHENOL DERIVATIVES USEFUL AS H3 LIGANDS WARNER LAMBERT CO (US) 2010-06-30 EP disclosed
US-7456164-B2 Useful for treatment of H3-related diseases such as neurologic disorders, or inflammatory, respiratory and allergic diseases, disorders and conditions; for example, 4-[4-(1-isopropylpiperidin-4-yloxy)phenyl]tetrahydropyran-4-carbonitrile; well absorbed from gastrointestinal tract, metabolically stable PFIZER, INC (US) 2008-11-25 US disclosed
EP-1747210-A1 3- OR 4-MONOSUBSTITUTED PHENOL AND THIOPHENOL DERIVATIVES USEFUL AS H3 LIGANDS Warner-Lambert Company LLC (US) 2007-01-31 EP disclosed
US-20050267095-A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands ZIARCO INC. 2005-12-01 US disclosed
WO-2005108384-A1 3- OR 4-MONOSUBSTITUTED PHENOL AND THIOPHENOL DERIVATIVES USEFUL AS H3 LIGANDS WARNER-LAMBERT COMPANY LLC (US) 2005-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050267095-A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands HRH4, HRH3, TLR4 SLC6A2 3564/4885SLC6A4 2629/4885POLB 2640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.